Loading insider details...
Beta
Latest Form 4 (Jun 13, 2026): Grant/Award of 5,500 JANX shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 13, 2026 | Janux Therapeutics, Inc. (JANX) | Grant/Award | 5,500 | n/a |
| Jun 11, 2026 | Corbus Pharmaceuticals Holdings, Inc. (CRBP) | Sale | 2,026 | $16.0K |
| May 21, 2026 | Corbus Pharmaceuticals Holdings, Inc. (CRBP) | Grant/Award | 3,800 | n/a |
| Feb 5, 2026 | ArriVent BioPharma, Inc. (AVBP) | Grant/Award | 140,000 | n/a |
| Jun 13, 2025 | Janux Therapeutics, Inc. (JANX) | Grant/Award | 3,750 | n/a |
| Jun 2, 2025 | Corbus Pharmaceuticals Holdings, Inc. (CRBP) | Grant/Award | 4,800 | n/a |
| Feb 14, 2025 | ArriVent BioPharma, Inc. (AVBP) | Grant/Award | 120,000 | n/a |
| Aug 20, 2024 | Corbus Pharmaceuticals Holdings, Inc. (CRBP) | Grant/Award | 5,566 | n/a |
| Jun 28, 2024 | Janux Therapeutics, Inc. (JANX) | Grant/Award | 2,500 | n/a |
| Jun 16, 2023 | Janux Therapeutics, Inc. (JANX) | Grant/Award | 12,500 | n/a |